NCT05651269 2022-12-15
Milciclib in Combination With Gemcitabine in Advanced NSCLC
Tiziana Life Sciences LTD
Phase 2 Unknown
Clinical Trials
9 trialsNCT05332574 2022-08-05
A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor
Genor Biopharma Co., Ltd.
Phase 1/2 Unknown
NCT05117658 2022-08-04
Study of HA121-28 in Patients With Non-Small Cell Lung Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2 Unknown
NCT05065398 2022-01-21
A Phase II Clinical Trial to Evaluate HLX208 in Advanced Non-small Cell Lung Cancer Patients With BRAF V600 Mutation
Shanghai Henlius Biotech
Phase 2 Unknown
NCT04874844 2021-05-10
JY025 is a First-line Treatment for EGFR Mutated NSCLC Phase II and III Clinical Trials of Efficacy and Safety
Beijing Dongfang Biotech Co., Ltd.
Phase 2/3 Unknown
NCT04390984 2021-01-11
Drug-drug Interaction Study of Gefitinb on Apatinib in NSCLC Patients
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Unknown
NCT04413227 2020-06-02
A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1 Unknown
NCT03453307 2018-03-05
Drug Sensitivity Correlation Between Patient-Derived Organoid Model and Clinical Response in NSCLC Patients
K2 Oncology, Inc.
Unknown
NCT02404675 2017-07-28
INCREASE
Betta Pharmaceuticals Co., Ltd.
Phase 4 Unknown